Exchange: TSXV·Updated 11:38 AM EDT

RX.TSXV BioSyent Inc.

$15.99
$0.11
(0.69%)
Today
Reported EarningsAug 20
Mkt Cap$179.58M
Vol2,234.00

About RX.TSXV

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
50

Neutral Sentiment

How do you feel about RX.TSXV?

Advertisement|Remove ads.